regn2477
mAbexperimental
Clinical trial activity
8 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
4
Phase 3
2
Phase 4
0
Earliest trial started Jul 1, 2016 (NCT02870400)
Timeline
Indications
Mechanism of action
- Inhibin beta A chainINHIBITOR
Inhibin beta A chain inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4298176 ↗
Also known as
- regn2477
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06970405 | Phase 1 | May 29, 2025 | Regeneron |
| NCT05394116 | Phase 3 | Nov 21, 2022 | Regeneron |
| NCT04577820 | Phase 3 | Nov 5, 2020 | Regeneron |
| NCT03710941 | Phase 2 | Feb 19, 2019 | Regeneron |
| NCT03188666 | Phase 2 | Oct 9, 2017 | Regeneron |
| NCT02943239 | Phase 1 | Dec 1, 2016 | Regeneron |
| NCT02870400 | Phase 1 | Jul 1, 2016 | Regeneron |
| NCT07301450 | N/A | — | Regeneron |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Regeneron | For profit | 8 | 8 | 4 | 2016 |
1 organizations
Page 1 / 1